biotech
biotech Articles
Biogen released better-than-expected second-quarter financial results before the markets opened on Tuesday.
Published:
Last Updated:
Reata shares saw a solid gain on Monday after the company reported results from a couple midstage kidney trials.
Published:
Last Updated:
24/7 Wall St. has put together a preview of AbbVie, Eli Lilly, Gilead Sciences and some of the other, larger health care companies that are about to report their quarterly results.
Published:
Last Updated:
Some biotech and biohealth stocks are receiving analyst coverage calling for 50%, 100%, 200% and even 300% upside price targets. There is no assurance that these upside targets will ever be reached...
Published:
Last Updated:
PTC Therapeutics shares made a handy gain on Friday after the firm announced that it would be acquiring Agilis Biotherapeutics.
Published:
Last Updated:
Mersana Therapeutics shares took a massive dive on Thursday morning after the company announced that the FDA put a partial hold on the firm’s early-stage cancer study.
Published:
Last Updated:
Rubius Therapeutics entered the market with a bang in its initial public offering.
Published:
Last Updated:
Voyager Therapeutics shares saw a handy gain on Tuesday after the company announced that it received some feedback from the FDA.
Published:
Last Updated:
Tonix Pharmaceuticals saw its shares make a solid gain to start off the week after the company announced an update from the FDA regarding its Alzheimer’s agitation treatment.
Published:
Last Updated:
Acceleron Pharma shares dipped on Friday after the company provided an update on an orphan drug designation from the FDA.
Published:
Last Updated:
Zogenix shares made a solid gain on Thursday after the company announced positive results from its late-stage seizure trial.
Published:
Last Updated:
The June 29 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
Published:
Last Updated:
Akcea Therapeutics shares saw a nice bump on Wednesday after the company announced in conjunction with Ionis Pharmaceuticals that they had received a marketing authorization approval from the...
Published:
Last Updated:
Idera Pharmaceuticals shares crumbled on Wednesday after BioCryst Pharmaceuticals announced that it terminated the merger agreement.
Published:
Last Updated:
AbbVie shares dipped on Wednesday after the company gave a less than impressive update from its late-stage lymphoma trial.
Published:
Last Updated: